{
    "clinical_study": {
        "@rank": "74029", 
        "arm_group": {
            "arm_group_label": "Non-Infiltrated Tissue", 
            "arm_group_type": "Experimental", 
            "description": "The ivWatch Model 400 monitored a common peripheral IV site over a 24 hour observation period."
        }, 
        "brief_summary": {
            "textblock": "A randomized study of 40 adult volunteers to assess the safety and efficacy of the ivWatch\n      Model 400 when observing non-infiltrated (normal) tissues at common peripheral IV therapy\n      sites."
        }, 
        "brief_title": "ivWatch Model 400: Device Validation for Non-Infiltrated Tissues", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Infiltration of Peripheral IV Therapy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent\n\n          -  Pass health screen\n\n          -  18 years or older\n\n        Exclusion Criteria:\n\n          -  Fail health screen"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "43", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02120443", 
            "org_study_id": "IVW400CS-05"
        }, 
        "intervention": {
            "arm_group_label": "Non-Infiltrated Tissue", 
            "description": "The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.", 
            "intervention_name": "ivWatch Model 400", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "infiltration", 
            "extravasation", 
            "peripheral intravenous therapy"
        ], 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Williamsburg", 
                    "country": "United States", 
                    "state": "Virginia", 
                    "zip": "23185"
                }, 
                "name": "ivWatch, LLC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "ivWatch Model 400: Device Validation for Non-Infiltrated Tissues", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "A measure for how often false red notifications are issued for subjects with normal (non-infiltrated) tissue.", 
            "measure": "False Red Notification Rate", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02120443"
        }, 
        "responsible_party": {
            "investigator_affiliation": "ivWatch, LLC", 
            "investigator_full_name": "Garret Bonnema", 
            "investigator_title": "Chief Science Officer", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "A measure for how often false yellow notifications are issued for subjects with normal (non-infiltrated) tissue.", 
                "measure": "False Yellow Notification Rate", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "The number of IV sites with significant skin irritation or disruption to skin integrity assessed at the end of the study.", 
                "measure": "Significant Skin Irritation or Disruption to Skin Integrity", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }
        ], 
        "source": "ivWatch, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ivWatch, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}